Suppr超能文献

新型口服活性强心剂异波帕胺在去大脑大鼠心血管系统中α和β肾上腺素能受体介导活性的评价:与去甲肾上腺素和多巴胺的比较

Evaluation of the alpha and beta adrenoceptor-mediated activities of the novel, orally active inotropic agent, ibopamine, in the cardiovascular system of the pithed rat: comparison with epinine and dopamine.

作者信息

Nichols A J, Ruffolo R R

出版信息

J Pharmacol Exp Ther. 1987 Aug;242(2):455-63.

PMID:3039117
Abstract

The alpha and beta adrenoceptor-mediated effects of the novel, orally active inotropic prodrug, ibopamine, have been studied in the pithed rat and compared with those effects mediated by dopamine and the active form of ibopamine, epinine. All three agents produced alpha adrenoceptor-mediated pressor responses in pithed rats, and the vasopressor effects of ibopamine and epinine, but not dopamine, were potentiated by beta adrenoceptor blockade with propranolol (3 mg/kg i.v.). Catecholamine depletion with reserpine (5 mg/kg i.p.) did not affect the vasoconstrictor response elicited by any of these agents, indicating a direct effect in the vasculature. Epinine was 10 times more potent than ibopamine or dopamine. The pressor response to all three agents was antagonized by the alpha-1 adrenoceptor antagonist, prazosin (0.1 mg/kg i.v.) and the alpha-2 adrenoceptor antagonist, rauwolscine (0.5 mg/kg i.v.), suggesting the involvement of both alpha adrenoceptor subtypes in the vasopressor responses elicited by these compounds. After complete blockade of alpha adrenoceptors using a combination of phenoxybenzamine (3 mg/kg i.v.), prazosin (0.1 mg/kg i.v.) and rauwolscine (1 mg/kg i.v.), higher doses of ibopamine, epinine and dopamine produced a propranolol-sensitive, beta-1 adrenoceptor-mediated positive chronotropic response that was significantly reduced in reserpine-pretreated rats, indicating a significant indirect component in the activity of these compounds at the level of the myocardium. Epinine and dopamine were equipotent and were 10 times more potent than ibopamine as directly acting beta-1 adrenoceptor agonists.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

新型口服活性强心前体药物异波帕胺的α和β肾上腺素能受体介导效应已在脊髓损伤大鼠中进行了研究,并与多巴胺和异波帕胺的活性形式依匹宁介导的效应进行了比较。所有这三种药物在脊髓损伤大鼠中均产生α肾上腺素能受体介导的升压反应,异波帕胺和依匹宁而非多巴胺的血管升压作用被普萘洛尔(3mg/kg静脉注射)的β肾上腺素能受体阻断所增强。利血平(5mg/kg腹腔注射)引起的儿茶酚胺耗竭并不影响这些药物中任何一种引起的血管收缩反应,表明其在血管系统中有直接作用。依匹宁的效力比异波帕胺或多巴胺强10倍。对所有这三种药物的升压反应均被α-1肾上腺素能受体拮抗剂哌唑嗪(0.1mg/kg静脉注射)和α-2肾上腺素能受体拮抗剂育亨宾(0.5mg/kg静脉注射)所拮抗,提示这两种α肾上腺素能受体亚型均参与了这些化合物引起的血管升压反应。在用酚苄明(3mg/kg静脉注射)、哌唑嗪(0.1mg/kg静脉注射)和育亨宾(1mg/kg静脉注射)联合完全阻断α肾上腺素能受体后,更高剂量的异波帕胺、依匹宁和多巴胺产生了一种普萘洛尔敏感的、β-1肾上腺素能受体介导的正性变时反应,该反应在利血平预处理的大鼠中显著降低,表明这些化合物在心肌水平的活性中有显著的间接成分。依匹宁和多巴胺等效,作为直接作用的β-1肾上腺素能受体激动剂,其效力比异波帕胺强10倍。(摘要截短至250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验